{"id": "1357513021007011849", "creation": 1612491300.0, "user_id": "1211892441529241601", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 3, "reply_count": 0, "like_count": 7, "quote_count": 1}}, "text": "#China's CanSino Biologics Inc. has got green light to continue phase-3 trials of its #COVID19 #vaccine with the support of findings of an independent data monitoring committee. The vaccine candidate-Ad5-nCoV, is developed by CanSino and the Academy of Military Sciences in China. https://t.co/NXNLUrJGCt", "first_save": 1634559108.199414, "hashtags": ["#CHINA", "#COVID19", "#VACCINE"]}